Top Markets
Coin of the day
OptiBiotix Health Plc OptiBiotix Health Plc

OptiBiotix Health Plc

OPTI
주식 순위 #40732
OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United... OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United Kingdom, specializes in the discovery and advancement of microbiome-modulating technologies. The company formulates distinct microbial strains, innovative compounds, and tailored blends intended for integration into food products, nutritional supplements, and active ingredients. Their groundbreaking work aims to positively influence human physiology and yield substantial health benefits. Among its diverse product portfolio are Slimbiome, a natural ingredient for healthy and satiety-driven weight management, and SlimBiome Medical, a supplemental aid for weight control. Other offerings include CholBiome, a dietary supplement for maintaining healthy cholesterol; Lactobacillus plantarum LPLDL, a probiotic supporting cardiovascular health and overall well-being; LPGOS, a galactooligosaccharide utilized in food applications to mitigate cardiovascular risk factors and enhance general health; WellBiome, a functional fiber and mineral blend designed to bolster gut microbiome diversity and promote wellness; and Sweetbiotix, a sweetener for use in various foods and beverages. Ultimately, OptiBiotix's innovations are designed to prevent and manage prevalent chronic lifestyle diseases, including obesity, high cholesterol, and diabetes. The company was founded in 2012.
주가
$0.07994122
마지막 동기화: 2026-09-25
시가총액
$82.58K
변동 (1일)
0.43%
변동 (1년)
-44.51%
국가
GB
거래 OptiBiotix Health Plc (OPTI)

카테고리

OptiBiotix Health Plc (OPTI)의 매출
Jun 2026 기준 매출 TTM: $1.75M
OptiBiotix Health Plc의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $1.75M입니다. 2023년에 회사는 $819.81K의 수익을 올렸으며 이는 2022년의 $552.88K 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
OptiBiotix Health Plc의 수익 기록 (2007 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $1.75M 60.54%
2024 $1.09M 33.16%
2023 $819.81K 48.28%
2022 $552.88K -81.52%
2021 $2.99M 43.69%
2020 $2.08M 110.80%
2019 $987.78K 50.50%
2018 $656.34K 153.86%
2017 $258.54K -28.31%
2016 $360.63K 749.11%
2015 $42.47K 0.00%
2014 0.00 0.00%
2013 0.00 -100.00%
2012 $253.34K 114.67%
2011 $118.01K 0.00%
2010 0.00 0.00%
2009 0.00 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
$12.62B 720,225.13%
US
$2.23B 127,026.60%
US
$6.02B 343,466.34%
NL
$15.74B 898,249.57%
AU
- -
CH